IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
2.610
-0.220 (-7.77%)
Nov 22, 2024, 4:00 PM EST - Market closed
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam, Central District Tel Aviv, 4690500 Israel | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Director |
| Uri Birenberg | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
| Advocate Michal Lebovitz Nissimov | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 20, 2024 | D | Notice of Exempt Offering of Securities |
| Nov 14, 2024 | 6-K | Report of foreign issuer |
| Nov 6, 2024 | 6-K | Report of foreign issuer |
| Nov 5, 2024 | 6-K | Report of foreign issuer |
| Oct 4, 2024 | 6-K | Report of foreign issuer |
| Oct 2, 2024 | 6-K | Report of foreign issuer |
| Oct 2, 2024 | 6-K | Report of foreign issuer |
| Sep 19, 2024 | 20-F/A | Filing |
| Sep 11, 2024 | 6-K | Report of foreign issuer |
| Sep 9, 2024 | 6-K | Report of foreign issuer |